BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prasher P, Sharma M, R Wich P, Jha NK, Singh SK, Chellappan DK, Dua K. Can dextran-based nanoparticles mitigate inflammatory lung diseases? Future Med Chem 2021;13:2027-31. [PMID: 34596425 DOI: 10.4155/fmc-2021-0218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Masanam HB, Perumal G, Krishnan S, Singh SK, Jha NK, Chellappan DK, Dua K, Gupta PK, Narasimhan AK. Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases. Nanomedicine (Lond) 2023. [PMID: 36695290 DOI: 10.2217/nnm-2021-0427] [Reference Citation Analysis]
2 Bhat AA, Gupta G, Alharbi KS, Afzal O, Altamimi ASA, Almalki WH, Kazmi I, Al-Abbasi FA, Alzarea SI, Chellappan DK, Singh SK, MacLoughlin R, Oliver BG, Dua K. Polysaccharide-Based Nanomedicines Targeting Lung Cancer. Pharmaceutics 2022;14. [PMID: 36559281 DOI: 10.3390/pharmaceutics14122788] [Reference Citation Analysis]
3 Prasher P, Sharma M, Singh SK, Haghi M, Macloughlin R, Chellappan DK, Gupta G, Paudel KR, Hansbro PM, George Oliver BG, Wich PR, Dua K. Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases. Journal of Drug Delivery Science and Technology 2022;74:103598. [DOI: 10.1016/j.jddst.2022.103598] [Reference Citation Analysis]